• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

朝着预防卵巢癌的方向努力。

Towards Prevention of Ovarian Cancer.

机构信息

Department of Pathology, Tygerberg Hospital and Stellenbosch Medical School, Cape-Town, South Africa.

出版信息

Curr Cancer Drug Targets. 2018;18(6):522-537. doi: 10.2174/1568009618666180102103008.

DOI:10.2174/1568009618666180102103008
PMID:29295697
Abstract

Ovarian cancer is the leading cause of death of all gynaecological cancers. To date, there is no reliable, specific screening procedure for detecting ovarian cancer. The risk factors of ovarian cancer include modifiable and non-modifiable factors. The main goal of the ovarian cancer prevention program is to significantly reduce the risk of development of ovarian cancer and other cancers such as breast and/or peritoneal cancer. The application of non-surgical preventive approaches such as oral contraceptives, parity and breastfeeding has been shown to be highly protective against ovarian cancer development. Targeting inflammation has been also reported to be associated with a protective trend against ovarian cancer and can be achieved through either non-steroidal antiinflammatory drugs (NSAIDs) such as aspirin or lifestyle modifications or both. Lifestyle modification that includes regular exercise, healthy diet supplemented with anti-oxidants and antiinflammatory elements reduces the risk of the disease even further. Surgical protective approaches include; tubal ligation, hysterectomy and prophylactic bilateral salpingo-oophorectomy and the former is the most effective approach to protect against ovarian cancer. A better understanding of the risk factors of ovarian cancer and the current approaches to prevent it may increase the awareness and help decrease the incidence of ovarian cancer, increase the five-year survival rate and decrease the mortality rate significantly in the general population especially among those at high risk for ovarian cancer. This review is an attempt to outline a potential program of ovarian cancer prevention and the potential challenges.

摘要

卵巢癌是妇科癌症死亡的主要原因。迄今为止,尚无可靠、特异的卵巢癌筛查程序。卵巢癌的危险因素包括可改变和不可改变的因素。卵巢癌预防计划的主要目标是显著降低卵巢癌和乳腺癌和/或腹膜癌等其他癌症的发病风险。已证实应用非手术预防方法,如口服避孕药、生育和哺乳,对预防卵巢癌的发生具有高度保护作用。针对炎症的治疗也被报道与预防卵巢癌的趋势有关,可通过非甾体类抗炎药(如阿司匹林)或生活方式改变或两者兼用来实现。包括定期锻炼、健康饮食补充抗氧化剂和抗炎元素的生活方式改变,甚至可以进一步降低患病风险。手术预防方法包括输卵管结扎术、子宫切除术和预防性双侧输卵管卵巢切除术,前者是预防卵巢癌最有效的方法。更好地了解卵巢癌的危险因素和当前的预防方法,可以提高认识,帮助降低卵巢癌的发病率,显著提高普通人群(尤其是卵巢癌高危人群)的五年生存率,降低死亡率。本文综述旨在概述卵巢癌的预防方案和潜在挑战。

相似文献

1
Towards Prevention of Ovarian Cancer.朝着预防卵巢癌的方向努力。
Curr Cancer Drug Targets. 2018;18(6):522-537. doi: 10.2174/1568009618666180102103008.
2
Can we prevent ovarian cancer?我们能预防卵巢癌吗?
Ceska Gynekol. 2020 Winter;85(1):49-58.
3
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
4
Prevention of ovarian cancer.卵巢癌的预防
Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):339-62. doi: 10.1016/j.bpobgyn.2005.10.016. Epub 2005 Dec 20.
5
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.降低卵巢癌和输卵管癌风险的干预措施:欧洲绝经与雄性激素缺乏协会立场声明
Maturitas. 2017 Jun;100:86-91. doi: 10.1016/j.maturitas.2017.03.003. Epub 2017 Mar 15.
6
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.输卵管卵巢切除术与携带BRCA1或BRCA2基因突变女性患卵巢癌、输卵管癌和腹膜癌的风险
JAMA. 2006 Jul 12;296(2):185-92. doi: 10.1001/jama.296.2.185.
7
A model for estimating ovarian cancer risk: application for preventive oophorectomy.一种评估卵巢癌风险的模型:预防性卵巢切除术的应用
Gynecol Oncol. 2015 Nov;139(2):242-7. doi: 10.1016/j.ygyno.2015.08.020. Epub 2015 Sep 2.
8
Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.具有上皮性卵巢癌潜在化学预防特性的药物——一项全国性病例对照研究。
Dan Med J. 2015 Jul;62(7).
9
[Chemoprevention and prophylactic surgery in ovarian carcinoma].卵巢癌的化学预防与预防性手术
J Gynecol Obstet Biol Reprod (Paris). 2007 Dec;36(8):756-63. doi: 10.1016/j.jgyn.2007.06.013. Epub 2007 Aug 23.
10
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.预防性手术以降低林奇综合征患者患妇科癌症的风险。
N Engl J Med. 2006 Jan 19;354(3):261-9. doi: 10.1056/NEJMoa052627.

引用本文的文献

1
Implication of CDKN2A in cuproptosis through defining cuproptosis-related gene signature in ovarian cancer.通过定义卵巢癌中与铜死亡相关的基因特征来探讨CDKN2A在铜死亡中的作用。
J Cancer. 2025 Jul 24;16(11):3355-3371. doi: 10.7150/jca.115374. eCollection 2025.
2
Integrative prognostic modeling of ovarian cancer: incorporating genetic, clinical, and immunological markers.卵巢癌的综合预后模型:纳入基因、临床和免疫标志物。
Discov Oncol. 2025 Feb 4;16(1):115. doi: 10.1007/s12672-025-01819-6.
3
Identification of immunogenic cell death gene-related subtypes and risk model predicts prognosis and response to immunotherapy in ovarian cancer.
免疫原性细胞死亡基因相关亚型的鉴定及风险模型预测卵巢癌的预后和免疫治疗反应
PeerJ. 2024 Dec 13;12:e18690. doi: 10.7717/peerj.18690. eCollection 2024.
4
A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers.帕博利珠单抗免疫疗法治疗乳腺癌和妇科癌症的临床、人文及经济价值的叙述性综述
Oncol Ther. 2024 Dec;12(4):701-734. doi: 10.1007/s40487-024-00308-0. Epub 2024 Oct 25.
5
Children's behaviour and childhood obesity.儿童行为与儿童肥胖。
Pediatr Endocrinol Diabetes Metab. 2024;30(3):148-158. doi: 10.5114/pedm.2024.142586.
6
Breastfeeding's protective role in alleviating breast cancer burden: a comprehensive review.母乳喂养在减轻乳腺癌负担方面的保护作用:一项综述
Ann Med Surg (Lond). 2024 Mar 5;86(5):2805-2811. doi: 10.1097/MS9.0000000000001914. eCollection 2024 May.
7
Epidemiology and risk factors for ovarian cancer.卵巢癌的流行病学及危险因素
Prz Menopauzalny. 2023 Jun;22(2):93-104. doi: 10.5114/pm.2023.128661. Epub 2023 Jun 14.
8
Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy.遗传性卵巢癌:迈向具有成本效益的预防策略。
Int J Environ Res Public Health. 2022 Sep 23;19(19):12057. doi: 10.3390/ijerph191912057.
9
MicroRNA-378a-3p contributes to ovarian cancer progression through downregulating PDIA4.miRNA-378a-3p 通过下调 PDIA4 促进卵巢癌进展。
Immun Inflamm Dis. 2021 Mar;9(1):108-119. doi: 10.1002/iid3.350. Epub 2020 Nov 7.
10
Lifestyle and reproductive health: the aetiology of ovarian cancer in Pakistan.生活方式和生殖健康:巴基斯坦卵巢癌的病因。
F1000Res. 2020 Aug 4;9:901. doi: 10.12688/f1000research.24866.1. eCollection 2020.